Docetaxel, Gemcitabine and Bevacizumab for Metastatic Breast Cancer
Clinical trial NCT00754351 · COMPLETED
Trial details
- NCT number
- NCT00754351
- Sponsor
- University Hospital of Crete
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2012-02-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.